ALK immunohistochemistry: what the result can mean

A pathologist evaluates the location and intensity of staining in tumour cells. The finding is interpreted alongside the cancer type, the appearance of the cells, and any molecular test results.

A positive result means the stain detected ALK protein in a pattern the pathologist considers relevant. In some tumours, this can suggest an ALK gene change, but the meaning depends on the tumour and the laboratory method. A molecular test may be used to confirm the underlying change before treatment is selected.

A negative result means the expected staining pattern was not seen. It does not by itself settle every question about the tumour. Sample quality, the amount of tumour present, previous testing, and the clinical context can affect whether another method is useful.

The report may describe staining as positive, negative, equivocal, or uninterpretable. Equivocal or uninterpretable findings often require review of the specimen or testing with a different technique.

Review the pathology report with the clinician managing your cancer. Ask whether the stain is being used as a screening test, a diagnostic clue, or evidence for choosing treatment. If confirmation is needed, the team may request molecular testing on the same tissue or discuss whether another sample is necessary.

Do not start, stop, or change cancer medicine based on the stain wording alone. A treatment decision also depends on the confirmed tumour diagnosis, other biomarker results, your overall health, previous therapy, and the options suitable for your situation.

An ALK staining result is not itself an emergency. Contact your care team promptly if you are waiting for a treatment decision and your symptoms are worsening, or if you develop a new problem that affects eating, drinking, movement, or normal daily activity.

Seek urgent medical care for severe difficulty breathing, chest pain, coughing up blood, sudden weakness, new confusion, a seizure, or any rapidly worsening symptom. These warning signs need assessment based on the symptom, regardless of the ALK result.

Useful questions include: Which tissue sample was tested? Was the result clearly positive or negative? Does this tumour require confirmation with a gene-based test? Is there enough tissue for that test? Could this finding change my treatment choices? When will the complete biomarker results be available?